Share Name Share Symbol Market Type Share ISIN Share Description
Proteome LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 3.10p 2.70p 3.50p - - - 717 16:29:59
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.8 -2.9 -1.0 - 9.13

Proteome Share Discussion Threads

Showing 178051 to 178069 of 178075 messages
Chat Pages: 7123  7122  7121  7120  7119  7118  7117  7116  7115  7114  7113  7112  Older
DateSubjectAuthorDiscuss
22/1/2018
20:13
Extract from an article by Matt Ridley in The Times today on why the UK lags behind other health services in capitalising on scientific/medical advances: __________________________ For example, the leaders of the Northern Irish company Randox, a world-leading pioneer in blood diagnostics with proteins, tear their hair out at how little they are able to benefit their home market, as opposed to overseas. They have tests that could save lives and money on a grand scale by earlier and fewer treatments. But the monolithic NHS cannot find it within its budget silos to buy such tests. Elsewhere in the world innovations that save lives and money are much more welcome. In the main pathology field of clinical chemistry and immunoassay testing (80 per cent of all testing) only one new test has been widely adopted by the NHS in the past ten years: high-sensitivity troponin for detecting myocardial infarction, or heart attack. That was adopted because a dominant private-sector provider effectively stopped producing an older test. The NHS realises the test is very useful, but industry insiders say that left to its own devices, it might not yet have adopted even this test. Randox now has a complementary test for heart attack management, based on fatty acid proteins, but although there is significant international interest the firm is struggling to get the NHS to adopt it. The fatty acid proteins are released into the bloodstream by damaged heart cells within 30 minutes, whereas troponin is released only when heart cells die after several hours. Combined with troponin, the test would more rapidly identify the one fifth of patients with chest pain in accident and emergency who need treatment and the four fifths who can be safely sent home, freeing up beds and saving about £225 million a year. Stem cells, gene therapy and gene editing promise a new generation of medicines for treating disease. However, proteomics and genomics are transforming diagnosis into a cheap, rapid and accurate process that is probably going to have an even bigger effect on most people’s health. The UK is good at inventing this stuff and selling it to the world, but terrible at applying it for the benefit of its citizens.
grahamburn
22/1/2018
18:00
Unless I am very much mistaken, that PRM one hour candle chart is actually the bar code for a small packet of Lidl own brand rich tea biscuits.
monte1
22/1/2018
17:15
Yep true adrenaline ride in the last week or so, oscillating between 3.09 and 3.1 pence PRMTASTIC ZZZZZZZZ
melodrama
22/1/2018
16:12
717 shares traded in the "World leader in applied Proteomics" says it all really.
peverill
22/1/2018
11:12
Splendid, thank you! now must rush and clean the bathroom..........
melodrama
22/1/2018
10:58
lol, not a bad guess melo, actually 2007 your prize of a free brunch is on its way, congratulations
elpirata
22/1/2018
10:54
Is that article straight from "Almost a boffin"?
saul goodman
22/1/2018
10:14
He's here all week folks!
saul goodman
22/1/2018
10:07
How do you hide from yourself?
goatherd
20/1/2018
22:00
17 January 2018 The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine. As people pack on pounds or shed excess weight, they exhibit notable changes in their microbiome, cardiovascular system, immune system and levels of gene expression, the study found. The researchers integrated a slew of "omics" profiling techniques to gather heaps of data revealing unique details of study participants' genomic, molecular, metabolic and bacterial composition. "Omics" is equivalent to tacking on "the study of" to the names of areas of biological inquiry. For example, "genomics" roughly translates to "the study of genes," and "proteomics" to "the study of proteins." A paper describing the work will be published online Jan. 17 in Cell Systems. Omics in the future of medicine However, a small subset of weight-gain-associated shifts in protein and molecule production did persist, even after participants had shed the extra pounds, the study found. There's not enough evidence to draw concrete clinical conclusions, "but it is an indication that some of these effects could be longer-lasting," Snyder said. One thing to note, he continued, is that even though there were trends in omics shifts, each participant exhibited particular changes to his or her own specific omics profile -- a nod to the importance of deep, integrative sequencing and data collection when diagnosing and treating patients with precision-health tools. "Big data will be critical to the future of medicine, and things like these integrative omics profiles will offer an understanding of how the human body responds, in a very personal way, to different challenges," Snyder said. "I think it will be a critical part of managing human health in the future." The work is an example of Stanford Medicine's focus on precision health, the goal of which is to anticipate and prevent disease in the healthy and precisely diagnose and treat disease in the ill. HTTPS://www.sciencedaily.com/releases/2018/01/180117131159.htm ---- Cell Systems Publication 17 January 2008 Integrative Personal Omics Profiles during Periods of Weight Gain and Loss SUMMARY Advances in omics technologies now allow an unprecedented level of phenotyping for human diseases, including obesity, in which individual responses to excess weight are heterogeneous and unpredictable. To aid the development of better understanding of these phenotypes, we performed a controlled longitudinal weight perturbation study combining multiple omics strategies (genomics, transcriptomics, multiple proteomics assays, metabolomics, and microbiomics) during periods of weight gain and loss in humans. Samples were then labeled with 10-plex Thermo Scientific Tandem Mass Tag (TMT) Reagents, using instructions provided by the manufacturer. All the samples were divided into groups of nine and pooled together with a master reference sample to create 10-plexed samples. HTTP://www.cell.com/pb-assets/journals/research/cell-systems/cels_393.pdf ==== TMT 10-plex reagent is sold through an exclusive Proteome Sciences licence to Thermo Fisher Scientific.
colinhy
20/1/2018
17:57
Very nice post and very nice (symmetrical) number to match for post 77277. I wondered though if that was really muttlly's bins? I just imagined all the 'booze' bottles would be scattered around a rather untidy bedroom*. *With cat and dog faeces scattered haphazardly across the sheets? Perhaps mutters could enlighten us whether this 'vision' is correct?
dunderheed
20/1/2018
16:00
Think Jezzer and the chap from UCB would have gotten on like a "house on fire"
melodrama
20/1/2018
14:13
I believe mutters may have provided certain social commentary about me previously and, (dont tell him but...) I secretly hope he may well provide some similar incisive 'stuff' in the near future as well? That would really make my weekend.
dunderheed
20/1/2018
14:06
And whilst we wait another £77k was blown down the old Swanee this week. I guess nobody’s getting paid at the moment.
jamtomorrow2
20/1/2018
13:54
Hear Hear!
melodrama
20/1/2018
10:21
77269 absolutely md. The addition of art to the earlier poetry was a really good evolution. Then the 'dernier cri' de muttlly topped it all! Sheer eloquence, wit, originality and beauty, summarised an excellent week of value. Please mutters, never stop these social observations, as they really make my Friday evenings.
dunderheed
20/1/2018
09:42
PRM - once I wasn't, then I was, soon I'm not again.
volsung
20/1/2018
09:22
Banter, Culture, and the occasional "Nigella experience" what more could one wish for on "teh free bb" Great value into the close Friday elpirata
melodrama
19/1/2018
22:48
evening baldrick wheres this prm trading statement
elpirata
Chat Pages: 7123  7122  7121  7120  7119  7118  7117  7116  7115  7114  7113  7112  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20180122 20:30:41